Bavarian Nordic A/S (BVNRY)
8.655
+0.14
(+1.58%)
USD |
OTCM |
May 24, 16:00
Bavarian Nordic Debt to Equity Ratio: 0.0016 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.0016 |
December 31, 2023 | 0.0016 |
September 30, 2023 | 0.0019 |
June 30, 2023 | 0.0851 |
March 31, 2023 | 0.0729 |
December 31, 2022 | 0.2362 |
September 30, 2022 | 0.2093 |
June 30, 2022 | 0.1995 |
March 31, 2022 | 0.1253 |
December 31, 2021 | 0.1429 |
September 30, 2021 | 0.1473 |
June 30, 2021 | 0.1211 |
March 31, 2021 | 0.0667 |
December 31, 2020 | 0.0808 |
September 30, 2020 | 0.0752 |
June 30, 2020 | 0.0755 |
March 31, 2020 | 0.0777 |
December 31, 2019 | 0.9491 |
September 30, 2019 | 0.2104 |
June 30, 2019 | 0.2007 |
March 31, 2019 | 0.1913 |
December 31, 2018 | 0.2965 |
September 30, 2018 | 0.285 |
June 30, 2018 | 0.3063 |
March 31, 2018 | 0.2196 |
Date | Value |
---|---|
December 31, 2017 | 0.1604 |
September 30, 2017 | 0.0115 |
June 30, 2017 | 0.0145 |
March 31, 2017 | 0.0154 |
December 31, 2016 | 0.0158 |
September 30, 2016 | 0.017 |
June 30, 2016 | 0.0179 |
March 31, 2016 | 0.0271 |
December 31, 2015 | 0.0248 |
September 30, 2015 | 0.0259 |
June 30, 2015 | 0.0254 |
March 31, 2015 | 0.0273 |
December 31, 2014 | 0.0281 |
September 30, 2014 | 0.0879 |
June 30, 2014 | 0.0826 |
March 31, 2014 | 0.0799 |
December 31, 2013 | 0.0823 |
September 30, 2013 | 0.0836 |
June 30, 2013 | 0.0882 |
March 31, 2013 | 0.0923 |
December 31, 2012 | 0.0894 |
September 30, 2012 | 0.088 |
June 30, 2012 | 0.0943 |
March 31, 2012 | 0.0797 |
December 31, 2011 | 0.0821 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0016
Minimum
Dec 2023
0.9491
Maximum
Dec 2019
0.154
Average
0.1031
Median
Debt to Equity Ratio Benchmarks
Genmab A/S | 0.00 |
Ascendis Pharma A/S | -2.809 |
Galecto Inc | -- |
Evaxion Biotech AS | -1.825 |
IO Biotech Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 1.970B |
Total Liabilities (Quarterly) | 498.58M |
Shareholders Equity (Quarterly) | 1.472B |
Current Ratio | 1.641 |
Net Debt Paydown Yield | 2.77% |